ATAD2 is directly associated with estrogen-bound ERα and ACTR, and thus elevates the expression of ERα-targeted cell cycle regulators, such as cyclin D1, Myc, and E2F1, which promote cancer cell proliferation [26,27]. Here, MYC is linked to cancer.